Provided are an insulin conjugate having improved insulin receptor binding affinity and increased activity, in which a non-peptidyl polymer and an immunoglobulin Fc region are site-specifically linked to an amino acid residue of the insulin beta chain excluding the N-terminus thereof via a covalent bond, a long-acting formulation including the same, and a preparation method thereof. The insulin conjugate of the present invention is used to provide an insulin formulation which exhibits a remarkably increased in vivo activity of the peptide.
Conjugates of an hGH moiety and one or more non-peptidic water-soluble polymers are provided. Typically, the non-peptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising such conjugates, methods of making the conjugates, and methods of administering compositions comprising such conjugates to a mammalian subject.
CONSIGLIO, G.;HALG, P.;PINO, P., ATTI ACAD. NAZ. LINCEI. REND. CL. SCI. FIS. MAT. E NATUR., 1980, 68, N 6,+
作者:CONSIGLIO, G.、HALG, P.、PINO, P.
DOI:——
日期:——
CONJUGATES OF AN HGH MOIETY AND PEG DERIVATIVES
申请人:Nektar Therapeutics Al, Corporation
公开号:EP1861125A2
公开(公告)日:2007-12-05
CONJUGATE OF IDURONATE-2-SULFATASE
申请人:HANMl PHARM. CO., LTD.
公开号:US20200230253A1
公开(公告)日:2020-07-23
Provided is a conjugate in which an immunoglobulin Fc region is linked to an iduronate-2-sulfatase enzyme through a non-peptide polymer linker moiety. Further, provided are a conjugate, a method for preparing the same, and a composition including the same in which a non-peptide polymer linker moiety is specifically linked to an immunoglobulin Fc.